SRx Health Solutions Inc.

SRX Global Inc. reported a fiscal third-quarter GAAP loss of $0.36 per share on revenue of $3.4 million. Operating loss improved 63% year over year to $3.2 million, while net loss from continuing operations narrowed 40% year over year and 35% quarter over quarter to $4.1 million. Adjusted EBITDA loss improved 35% year over year to $1.6 million. The company ended the quarter with $36.7 million in cash, cash equivalents and restricted cash, $65.2 million in current assets, and $2.4 million in total liabilities with no debt outstanding. SRX Global also approved a 10 million share repurchase program and declared a one-time cash dividend of $0.05 per share, about $1.3 million in aggregate, to shareholders of record on July 22, 2026.

SRX Global announced it acquired shares in the initial public offering of Jersey Mike’s, a fast-casual restaurant franchisor with more than 3,300 locations across the United States and Canada. Jersey Mike’s priced its Class A common shares at $23.00 per share at a total valuation of $1 billion and began trading on the New York Stock Exchange under the ticker JMKE. SRX Global is an AI-enabled platform focused on generating long-term shareholder value through investments in high-conviction operating companies and strategic assets.

SRX Global announced that CEO Kent Cunningham and President of EMJX Eric Jackson will participate in a virtual Fireside Chat on Tuesday, July 14, 2026, at 10:30 a.m. ET to discuss recent developments, the completed EMJX acquisition, and future vision. The company also issued a letter to shareholders highlighting over $55 million in cash and short-term investments with no debt, representing a net asset value of approximately $3.07 per share. SRX Global disclosed a share repurchase program for up to 10 million common shares and a dividend of approximately $1 million in cash from its SpaceX investment and hedging strategy. The letter outlined an investment framework built on three pillars—control investments, minority investments, and special situations—leveraging AI capabilities across sourcing, diligence, and operational execution. Capital allocation priorities include preserving balance sheet strength, deploying excess liquidity into a fixed-income portfolio, investing in the Halo pet food brand, and pursuing strategic acquisitions.

SRX Global's Board of Directors has authorized a share repurchase program allowing the company to buy back up to 10 million shares of its common stock, representing up to 50% of its shares outstanding. The company has allocated up to $20 million for the program, which runs until July 9, 2027. CEO Kent Cunningham stated that with no debt, a strong cash position, and the current market value of the shares, the repurchase program is a compelling use of capital and reflects the board's confidence in SRX's long-term strategy. Repurchases may be conducted in open market or private transactions, funded by cash on hand, and are subject to market conditions and other factors.

SRX Global announced preliminary balance sheet results following its acquisition of EMJX and a 1-for-60 reverse stock split, reporting an estimated net asset value of approximately $60 million, or $3.07 per common share, as of June 30, 2026. The company held about $40 million in cash and more than $15 million in short-term investments, with no debt outstanding, and now has roughly 19.5 million shares outstanding on a post-split basis. CEO Kent Cunningham stated that the elimination of debt and completion of the EMJX acquisition have positioned SRX with one of the strongest balance sheets in its history, and management does not anticipate the need for an additional capital raise in the near term. SRX outlined a disciplined capital allocation framework including maintaining financial flexibility, optimizing treasury returns through a diversified fixed-income portfolio, reinvesting in Halo to drive product innovation and growth, and pursuing strategic investments and acquisitions. SRXH closed Wednesday's trading at $1.97, up 45.93%, and during overnight trading the stock was at $2.11, up 7.11%.